{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:09:18Z","timestamp":1780790958915,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p><jats:italic>HTR2A<\/jats:italic> is previously identified as a susceptibility gene for rheumatoid arthritis (RA). In this study, we performed the association analysis between DNA methylation of <jats:italic>HTR2A<\/jats:italic> with RA within peripheral blood samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We enrolled peripheral blood samples from 235 patients with RA, 30 osteoarthritis (OA) patients, and 30 healthy controls. The DNA methylation levels of about <jats:italic>218 bp<\/jats:italic> from chr13: 46898190 to chr13: 46897973 (GRCh38\/hg38) around <jats:italic>HTR2A<\/jats:italic> cg15692052 from patients were analyzed by targeted methylation sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We measured methylation status for 7 CpGs in the promoter region of <jats:italic>HTR2A<\/jats:italic> and obseved overall methylation status are signficantly increased in RA compared with normal inviduals (FDR= 9.05 x 10<jats:sup>-5<\/jats:sup>). The average cg15692052 methylation levels (methylation score) showed a positive correlation with CRP (r=0.15, <jats:italic>P<\/jats:italic>=0.023). Compared with the OA group or HC group, the proportion of haplotypes CCCCCCC (<jats:italic>FDR<\/jats:italic>=0.02 and 2.81 x 10<jats:sup>-6<\/jats:sup>) is signficantly increased while TTTTTCC (<jats:italic>FDR<\/jats:italic> =0.01) and TTTTTTT(<jats:italic>FDR<\/jats:italic> =6.92 x 10<jats:sup>-3<\/jats:sup>) are significantly decreased in RA. We find methylation haplotypes combining with RF and CCP could signficantly enhance the performance of the diagnosing RA and its comorbidities (hypertension, interstitial lung disease, and osteoporosis), especially in interstitial lung disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In our study, we found signficant hypermethylation of promoter region of <jats:italic>HTR2A<\/jats:italic> which indicates the potential clinical diagnostic role in rheumatoid arthritis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1054451","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T04:38:28Z","timestamp":1670301508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Circulating methylation level of HTR2A is associated with inflammation and disease activity in rheumatoid arthritis"],"prefix":"10.3389","volume":"13","author":[{"given":"Jianan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linshuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Schrodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790122","article-title":"Molecular and cellular heterogeneity in rheumatoid arthritis: Mechanisms and clinical implications","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.809806","article-title":"Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrrheum.2017.147","article-title":"New insights into the epigenetics of inflammatory rheumatic diseases","volume":"13","author":"Ballestar","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838884","article-title":"MicroRNA-mediated epigenetic regulation of rheumatoid arthritis susceptibility and pathogenesis","volume":"13","author":"Chang","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.863703","article-title":"DNA Methylation of T lymphocytes as a therapeutic target: Implications for rheumatoid arthritis etiology","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2217\/epi.15.103","article-title":"Genome-wide profiling in treatment-naive early rheumatoid arthritis reveals DNA methylome changes in T and b lymphocytes","volume":"8","author":"Glossop","year":"2016","journal-title":"Epigenomics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2217\/epi.15.15","article-title":"DNA Methylation profiling of synovial fluid FLS in rheumatoid arthritis reveals changes common with tissue-derived FLS","volume":"7","author":"Glossop","year":"2015","journal-title":"Epigenomics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4161\/epi.26265","article-title":"Epigenome-wide profiling identifies significant differences in DNA methylation between matched-pairs of T- and b-lymphocytes from healthy individuals","volume":"8","author":"Glossop","year":"2013","journal-title":"Epigenetics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2016-0042","article-title":"DNA Methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis","volume":"9","author":"Glossop","year":"2017","journal-title":"Epigenomics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx177","article-title":"Epigenome-wide association study of rheumatoid arthritis identifies differentially methylated loci in b cells","volume":"26","author":"Juli\u00e0","year":"2017","journal-title":"Hum Mol Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444453","article-title":"A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis treg cells","volume":"44","author":"Kennedy","year":"2014","journal-title":"Eur J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.39031","article-title":"Methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis","volume":"67","author":"Cribbs","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.12","article-title":"Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis","volume":"18","author":"Seddighzadeh","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.04.007","article-title":"Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder","volume":"129","author":"Abdolmaleky","year":"2011","journal-title":"Schizophr Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.31192","article-title":"Hypomethylation of the serotonin receptor type-2A gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder","author":"Ghadirivasfi","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2008.07.007","article-title":"Methylation and QTDT analysis of the 5-HT2A receptor 102C allele: analysis of suicidality in major psychosis","volume":"43","author":"De Luca","year":"2009","journal-title":"J Psychiatr Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12017-010-8138-2","article-title":"Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association","volume":"13","author":"Falkenberg","year":"2011","journal-title":"Neuromolecular Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.1998.tb10168.x","article-title":"Serotonin receptor variants in disease: new therapeutic opportunities","volume":"861","author":"Peroutka","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.074948","article-title":"Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis","volume":"67","author":"Kling","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2012.56","article-title":"Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis","volume":"14","author":"Snir","year":"2013","journal-title":"Genes Immun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: The 'ggstatsplot' approach","volume":"6","author":"Patil","year":"2021","journal-title":"J Open Source Software"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700039702","article-title":"Psychological aspects of rheumatoid arthritis","volume":"10","author":"Gardiner","year":"1980","journal-title":"Psychol Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.98.2.358","article-title":"Rheumatoid arthritis: review of psychological factors related to etiology, effects, and treatment","volume":"98","author":"Anderson","year":"1985","journal-title":"Psychol Bull"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000288114","article-title":"Experiences in the psychotherapy of rheumatoid arthritis","volume":"50","author":"Lindberg","year":"1988","journal-title":"Psychother Psychosom"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.23.14825","article-title":"Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak\/STAT pathway","volume":"272","author":"Guillet-Deniau","year":"1997","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxg027","article-title":"Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: Involvement of 5-hydroxytryptamine2A receptors","volume":"15","author":"Clo\u00ebz-Tayarani","year":"2003","journal-title":"Int Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency","volume":"327","author":"Yu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.799440","article-title":"RNA-Seq and network analysis reveal unique chemokine activity signatures in the synovial tissue of patients with rheumatoid arthritis","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann Intern Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg083","article-title":"Rheumatoid arthritis and macrovascular disease","volume":"42","author":"Alkaabi","year":"2003","journal-title":"Rheumatol (Oxford)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","article-title":"Cardiovascular comorbidity in rheumatic diseases","volume":"11","author":"Nurmohamed","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.55563\/clinexprheumatol\/5r53em","article-title":"Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study","volume":"39","author":"Ruscitti","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem169","article-title":"Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis","volume":"46","author":"Panoulas","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"104354","DOI":"10.1016\/j.phrs.2019.104354","article-title":"Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis","volume":"147","author":"Orsolini","year":"2019","journal-title":"Pharmacol Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2001.16648","article-title":"Osteoporosis therapies for rheumatoid arthritis patients: minimizing gastrointestinal side effects","volume":"30","author":"Sewell","year":"2001","journal-title":"Semin Arthritis Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1054451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T04:38:31Z","timestamp":1670301511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1054451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2022.1054451"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1054451","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"1054451"}}